BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 23034655)

  • 1. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.
    Demjaha A; Murray RM; McGuire PK; Kapur S; Howes OD
    Am J Psychiatry; 2012 Nov; 169(11):1203-10. PubMed ID: 23034655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
    Howes OD; Montgomery AJ; Asselin MC; Murray RM; Valli I; Tabraham P; Bramon-Bosch E; Valmaggia L; Johns L; Broome M; McGuire PK; Grasby PM
    Arch Gen Psychiatry; 2009 Jan; 66(1):13-20. PubMed ID: 19124684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [
    Kim E; Howes OD; Veronese M; Beck K; Seo S; Park JW; Lee JS; Lee YS; Kwon JS
    Neuropsychopharmacology; 2017 Mar; 42(4):941-950. PubMed ID: 27857125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.
    Eisenberg DP; Yankowitz L; Ianni AM; Rubinstein DY; Kohn PD; Hegarty CE; Gregory MD; Apud JA; Berman KF
    Neuropsychopharmacology; 2017 Oct; 42(11):2232-2241. PubMed ID: 28387222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [
    Kim S; Jung WH; Howes OD; Veronese M; Turkheimer FE; Lee YS; Lee JS; Kim E; Kwon JS
    Psychol Med; 2019 Nov; 49(15):2533-2542. PubMed ID: 30460891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study.
    D'Ambrosio E; Dahoun T; Pardiñas AF; Veronese M; Bloomfield MAP; Jauhar S; Bonoldi I; Rogdaki M; Froudist-Walsh S; Walters JTR; Howes OD
    Psychiatry Res Neuroimaging; 2019 Sep; 291():34-41. PubMed ID: 31386983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms.
    Avram M; Brandl F; Cabello J; Leucht C; Scherr M; Mustafa M; Leucht S; Ziegler S; Sorg C
    Brain; 2019 Jun; 142(6):1813-1826. PubMed ID: 31135051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study.
    Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Natesan S; Turkheimer F; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
    Biol Psychiatry; 2019 Jan; 85(1):79-87. PubMed ID: 30122287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.
    Hietala J; Syvälahti E; Vilkman H; Vuorio K; Räkköläinen V; Bergman J; Haaparanta M; Solin O; Kuoppamäki M; Eronen E; Ruotsalainen U; Salokangas RK
    Schizophr Res; 1999 Jan; 35(1):41-50. PubMed ID: 9988840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis.
    Allen P; Chaddock CA; Howes OD; Egerton A; Seal ML; Fusar-Poli P; Valli I; Day F; McGuire PK
    Schizophr Bull; 2012 Sep; 38(5):1040-9. PubMed ID: 21536784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of treatment response in first-episode psychosis: an
    Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Turkheimer FE; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
    Mol Psychiatry; 2019 Oct; 24(10):1502-1512. PubMed ID: 29679071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium.
    Yatham LN; Liddle PF; Shiah IS; Lam RW; Ngan E; Scarrow G; Imperial M; Stoessl J; Sossi V; Ruth TJ
    Am J Psychiatry; 2002 May; 159(5):768-74. PubMed ID: 11986130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study.
    Howes OD; Williams M; Ibrahim K; Leung G; Egerton A; McGuire PK; Turkheimer F
    Brain; 2013 Nov; 136(Pt 11):3242-51. PubMed ID: 24097339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.
    Bloomfield MA; Pepper F; Egerton A; Demjaha A; Tomasi G; Mouchlianitis E; Maximen L; Veronese M; Turkheimer F; Selvaraj S; Howes OD
    Neuropsychopharmacology; 2014 Sep; 39(10):2397-404. PubMed ID: 24718373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study.
    Bloomfield MA; Morgan CJ; Kapur S; Curran HV; Howes OD
    Psychopharmacology (Berl); 2014 Jun; 231(11):2251-9. PubMed ID: 24696078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
    Kegeles LS; Abi-Dargham A; Frankle WG; Gil R; Cooper TB; Slifstein M; Hwang DR; Huang Y; Haber SN; Laruelle M
    Arch Gen Psychiatry; 2010 Mar; 67(3):231-9. PubMed ID: 20194823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.
    Howes OD; Egerton A; Allan V; McGuire P; Stokes P; Kapur S
    Curr Pharm Des; 2009; 15(22):2550-9. PubMed ID: 19689327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant striatal dopamine links topographically with cortico-thalamic dysconnectivity in schizophrenia.
    Avram M; Brandl F; Knolle F; Cabello J; Leucht C; Scherr M; Mustafa M; Koutsouleris N; Leucht S; Ziegler S; Sorg C
    Brain; 2020 Dec; 143(11):3495-3505. PubMed ID: 33155047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
    Egerton A; Murphy A; Donocik J; Anton A; Barker GJ; Collier T; Deakin B; Drake R; Eliasson E; Emsley R; Gregory CJ; Griffiths K; Kapur S; Kassoumeri L; Knight L; Lambe EJB; Lawrie SM; Lees J; Lewis S; Lythgoe DJ; Matthews J; McGuire P; McNamee L; Semple S; Shaw AD; Singh KD; Stockton-Powdrell C; Talbot PS; Veronese M; Wagner E; Walters JTR; Williams SR; MacCabe JH; Howes OD
    Schizophr Bull; 2021 Mar; 47(2):505-516. PubMed ID: 32910150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.